| Ytd | -42.10% | |
| 1y | -56.32% |
| Open | 0.54 | Prev Close | 0.54 | Low | 0.54 | High | 0.54 | Mkt Cap | 5.40M |
| Vol | 2.09K | Avg Vol | 1.43M | EPS | -2.90 | P/E | N/A | Forward P/E | -1.09 |
| Beta | 1.84 | Short Ratio | 0.86 | Inst. Own | 2.44% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.56 | 200-d Avg | 0.79 | 1yr Est | 27.60 |
DSS News
Gainers Eos Energy Enterprises (NASDAQ:EOSE) stock rose 11.9% to $4.89 during Wednesday's after
Gainers Julong Holding (NASDAQ:JLHL) stock rose 80.6% to $23.1 during Thursday's after-market s
DSS, Inc. (NYSE:DSS) today announced that it has withdrawn its previously filed Registration Stateme
NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) today announced that it h
ImmunityBio, Inc. ([url="]NASDAQ: IBRX[/url]), a commercial-stage immunotherapy company, today annou
DSS (AMEX:DSS) reported quarterly losses of $(0.60) per share which missed the analyst consensus est
DSS, Inc. (NYSE:DSS) announced that its annual report (10-K) for the fiscal year ending December 31,
ROCHESTER, N.Y., May 08, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) announced that its
ROCHESTER, N. Y. , April 15, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) today issued th
Impact Biomedical shares jumped 86% after hours following amended merger terms with Dr Ashleys Bio L
DSS, Inc. (NYSE:DSS) (the "Company"), a multinational company operating across diverse indus
NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) (the “Company”), a multin
NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE: DSS) (the “Company”), a multinational c
NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE: DSS) (the “Company”), a multinational c
https://register.epo.org/application?number=EP18855104
On July 21, 2025, Impact BioMedical Inc. (the "Company" or "Borrower") entered into
DSS, Inc. (NYSE:DSS) ("DSS" or the "Company"), a multinational company operating acr